Zacks Research Upgrades Accendra Health (NYSE:ACH) to Hold

Accendra Health (NYSE:ACH) was upgraded by research analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a research report issued on Tuesday, Zacks reports.

ACH has been the subject of several other reports. UBS Group lowered their price objective on shares of Accendra Health from $4.50 to $1.50 and set a “neutral” rating for the company in a research report on Thursday, August 13th. Citigroup downgraded Accendra Health from a “buy” rating to a “neutral” rating and reduced their target price for the company from $4.50 to $1.50 in a report on Monday, August 10th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Accendra Health in a report on Tuesday. Finally, Robert W. Baird lowered Accendra Health from an “outperform” rating to a “neutral” rating and set a $1.50 price target on the stock. in a research note on Tuesday, August 11th. Four research analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Reduce” and a consensus price target of $1.50.

Accendra Health Trading Down 2.7%

Shares of NYSE:ACH opened at $0.28 on Tuesday. The firm has a 50 day moving average of $0.66 and a 200-day moving average of $2.14. Accendra Health has a 12 month low of $0.19 and a 12 month high of $4.69. The stock has a market capitalization of $21.17 million, a PE ratio of -0.07 and a beta of 1.60.

Accendra Health (NYSE:ACH) last posted its quarterly earnings results on Monday, August 10th. The company reported ($0.19) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.13) by ($0.06). The firm had revenue of $613.23 million for the quarter. Accendra Health had a negative return on equity of 4.02% and a negative net margin of 11.41%. On average, research analysts predict that Accendra Health will post -0.03 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of ACH. Corient Private Wealth LP acquired a new stake in shares of Accendra Health in the 2nd quarter valued at approximately $40,000. Walleye Capital LLC bought a new stake in shares of Accendra Health during the 1st quarter valued at approximately $27,000. Hsbc Holdings PLC bought a new stake in shares of Accendra Health during the 1st quarter valued at approximately $34,000. Abel Hall LLC acquired a new position in Accendra Health during the 1st quarter worth approximately $44,000. Finally, The Manufacturers Life Insurance Company acquired a new position in Accendra Health during the 2nd quarter worth approximately $68,000.

About Accendra Health

Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services.